Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation
Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, stroke, and death. Enhanced understanding of modifiable risk factors may yield opportunities for prevention. The risk of AF is increased in subclinical hyperthyroidism, but it is uncertain whether variations in thyroid...
Saved in:
Published in | Circulation (New York, N.Y.) Vol. 136; no. 22; pp. 2100 - 2116 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
28.11.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 0009-7322 1524-4539 1524-4539 |
DOI | 10.1161/CIRCULATIONAHA.117.028753 |
Cover
Abstract | Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, stroke, and death. Enhanced understanding of modifiable risk factors may yield opportunities for prevention. The risk of AF is increased in subclinical hyperthyroidism, but it is uncertain whether variations in thyroid function within the normal range or subclinical hypothyroidism are also associated with AF.
We conducted a systematic review and obtained individual participant data from prospective cohort studies that measured thyroid function at baseline and assessed incident AF. Studies were identified from MEDLINE and EMBASE databases from inception to July 27, 2016. The euthyroid state was defined as thyroid-stimulating hormone (TSH) 0.45 to 4.49 mIU/L, and subclinical hypothyroidism as TSH 4.5 to 19.9 mIU/L with free thyroxine (fT4) levels within reference range. The association of TSH levels in the euthyroid and subclinical hypothyroid range with incident AF was examined by using Cox proportional hazards models. In euthyroid participants, we additionally examined the association between fT4 levels and incident AF.
Of 30 085 participants from 11 cohorts (278 955 person-years of follow-up), 1958 (6.5%) had subclinical hypothyroidism and 2574 individuals (8.6%) developed AF during follow-up. TSH at baseline was not significantly associated with incident AF in euthyroid participants or those with subclinical hypothyroidism. Higher fT4 levels at baseline in euthyroid individuals were associated with increased AF risk in age- and sex-adjusted analyses (hazard ratio, 1.45; 95% confidence interval, 1.26-1.66, for the highest quartile versus the lowest quartile of fT4;
for trend ≤0.001 across quartiles). Estimates did not substantially differ after further adjustment for preexisting cardiovascular disease.
In euthyroid individuals, higher circulating fT4 levels, but not TSH levels, are associated with increased risk of incident AF. |
---|---|
AbstractList | Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, stroke, and death. Enhanced understanding of modifiable risk factors may yield opportunities for prevention. The risk of AF is increased in subclinical hyperthyroidism, but it is uncertain whether variations in thyroid function within the normal range or subclinical hypothyroidism are also associated with AF.
We conducted a systematic review and obtained individual participant data from prospective cohort studies that measured thyroid function at baseline and assessed incident AF. Studies were identified from MEDLINE and EMBASE databases from inception to July 27, 2016. The euthyroid state was defined as thyroid-stimulating hormone (TSH) 0.45 to 4.49 mIU/L, and subclinical hypothyroidism as TSH 4.5 to 19.9 mIU/L with free thyroxine (fT4) levels within reference range. The association of TSH levels in the euthyroid and subclinical hypothyroid range with incident AF was examined by using Cox proportional hazards models. In euthyroid participants, we additionally examined the association between fT4 levels and incident AF.
Of 30 085 participants from 11 cohorts (278 955 person-years of follow-up), 1958 (6.5%) had subclinical hypothyroidism and 2574 individuals (8.6%) developed AF during follow-up. TSH at baseline was not significantly associated with incident AF in euthyroid participants or those with subclinical hypothyroidism. Higher fT4 levels at baseline in euthyroid individuals were associated with increased AF risk in age- and sex-adjusted analyses (hazard ratio, 1.45; 95% confidence interval, 1.26-1.66, for the highest quartile versus the lowest quartile of fT4;
for trend ≤0.001 across quartiles). Estimates did not substantially differ after further adjustment for preexisting cardiovascular disease.
In euthyroid individuals, higher circulating fT4 levels, but not TSH levels, are associated with increased risk of incident AF. Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, stroke, and death. Enhanced understanding of modifiable risk factors may yield opportunities for prevention. The risk of AF is increased in subclinical hyperthyroidism, but it is uncertain whether variations in thyroid function within the normal range or subclinical hypothyroidism are also associated with AF.BACKGROUNDAtrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, stroke, and death. Enhanced understanding of modifiable risk factors may yield opportunities for prevention. The risk of AF is increased in subclinical hyperthyroidism, but it is uncertain whether variations in thyroid function within the normal range or subclinical hypothyroidism are also associated with AF.We conducted a systematic review and obtained individual participant data from prospective cohort studies that measured thyroid function at baseline and assessed incident AF. Studies were identified from MEDLINE and EMBASE databases from inception to July 27, 2016. The euthyroid state was defined as thyroid-stimulating hormone (TSH) 0.45 to 4.49 mIU/L, and subclinical hypothyroidism as TSH 4.5 to 19.9 mIU/L with free thyroxine (fT4) levels within reference range. The association of TSH levels in the euthyroid and subclinical hypothyroid range with incident AF was examined by using Cox proportional hazards models. In euthyroid participants, we additionally examined the association between fT4 levels and incident AF.METHODSWe conducted a systematic review and obtained individual participant data from prospective cohort studies that measured thyroid function at baseline and assessed incident AF. Studies were identified from MEDLINE and EMBASE databases from inception to July 27, 2016. The euthyroid state was defined as thyroid-stimulating hormone (TSH) 0.45 to 4.49 mIU/L, and subclinical hypothyroidism as TSH 4.5 to 19.9 mIU/L with free thyroxine (fT4) levels within reference range. The association of TSH levels in the euthyroid and subclinical hypothyroid range with incident AF was examined by using Cox proportional hazards models. In euthyroid participants, we additionally examined the association between fT4 levels and incident AF.Of 30 085 participants from 11 cohorts (278 955 person-years of follow-up), 1958 (6.5%) had subclinical hypothyroidism and 2574 individuals (8.6%) developed AF during follow-up. TSH at baseline was not significantly associated with incident AF in euthyroid participants or those with subclinical hypothyroidism. Higher fT4 levels at baseline in euthyroid individuals were associated with increased AF risk in age- and sex-adjusted analyses (hazard ratio, 1.45; 95% confidence interval, 1.26-1.66, for the highest quartile versus the lowest quartile of fT4; P for trend ≤0.001 across quartiles). Estimates did not substantially differ after further adjustment for preexisting cardiovascular disease.RESULTSOf 30 085 participants from 11 cohorts (278 955 person-years of follow-up), 1958 (6.5%) had subclinical hypothyroidism and 2574 individuals (8.6%) developed AF during follow-up. TSH at baseline was not significantly associated with incident AF in euthyroid participants or those with subclinical hypothyroidism. Higher fT4 levels at baseline in euthyroid individuals were associated with increased AF risk in age- and sex-adjusted analyses (hazard ratio, 1.45; 95% confidence interval, 1.26-1.66, for the highest quartile versus the lowest quartile of fT4; P for trend ≤0.001 across quartiles). Estimates did not substantially differ after further adjustment for preexisting cardiovascular disease.In euthyroid individuals, higher circulating fT4 levels, but not TSH levels, are associated with increased risk of incident AF.CONCLUSIONSIn euthyroid individuals, higher circulating fT4 levels, but not TSH levels, are associated with increased risk of incident AF. |
Author | Collet, Tinh-Hai Bauer, Douglas C. Westendorp, Rudi G. J. Gussekloo, Jacobijn da Costa, Bruno R. Völzke, Henry Floriani, Carmen Cappola, Anne R. Heeringa, Jan Aujesky, Drahomir Ceresini, Graziano Peeters, Robin P. Khaw, Kay-Tee Walsh, John P. Baumgartner, Christine Rodondi, Nicolas Bremner, Alexandra Dörr, Marcus den Elzen, Wendy P.J. Macfarlane, Peter Magnani, Jared W. Luben, Robert Stott, David J. Heckbert, Susan R. Iacoviello, Massimo Feller, Martin |
AuthorAffiliation | 20 Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom 19 Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands 16 School of Population Health, University of Western Australia, Crawley, WA, Australia 8 Department of Public Health and Primary Care, and Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands 18 Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom 2 Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland 10 Departments of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands 22 Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States 9 Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands 15 Department of Endocrinology & Diabetes, Sir Charles Gairdner Ho |
AuthorAffiliation_xml | – name: 7 Department of Clinical and Experimental Medicine, Geriatric Endocrine Unit, University Hospital of Parma, Parma, Italy – name: 22 Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States – name: 10 Departments of Internal Medicine and Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands – name: 9 Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands – name: 13 Department of Internal Medicine, University Medicine Greifswald, Greifswald, Germany and German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany – name: 14 School of Medicine and Pharmacology, University of Western Australia, Crawley, WA, Australia – name: 18 Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom – name: 21 Department of Public Health and Center for Healthy Ageing, University of Copenhagen, Copenhagen, Denmark – name: 4 Departments of Medicine and Epidemiology & Biostatistics, University of California, San Francisco, San Francisco, CA, United States – name: 16 School of Population Health, University of Western Australia, Crawley, WA, Australia – name: 3 Service of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne, Lausanne, Switzerland – name: 12 Institute for Community Medicine, Clinical-Epidemiological Research, University Medicine Greifswald, Greifswald, Germany and German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany – name: 20 Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom – name: 8 Department of Public Health and Primary Care, and Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands – name: 11 Department of Public Health and Primary Care, University of Cambridge, Addenbrooke's Hospital, Cambridge, United Kingdom – name: 6 Department of Epidemiology, University of Washington, Seattle, WA, United States – name: 1 Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland – name: 2 Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland – name: 17 Cardiology Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy – name: 19 Department of Epidemiology and Biostatistics, Erasmus Medical Center, Rotterdam, The Netherlands – name: 5 University of Pennsylvania School of Medicine, Philadelphia, PA, United States – name: 15 Department of Endocrinology & Diabetes, Sir Charles Gairdner Hospital, Nedlands, WA, Australia |
Author_xml | – sequence: 1 givenname: Christine surname: Baumgartner fullname: Baumgartner, Christine organization: Department of General Internal Medicine, Inselspital, Bern University Hospital, (C.B., M.F., C.F., D.A., N.R.) – sequence: 2 givenname: Bruno R. surname: da Costa fullname: da Costa, Bruno R. organization: Institute of Primary Health Care (BIHAM) (B.R.d.C., M.F., N.R.), University of Bern, Switzerland; Applied Health Research Centre (AHRC), Li Ka Shing Knowledge Institute of St. Michael's Hospital, Institue of Health Policy, Management, and Evaluation, University of Toronto, Toronto, Ontario, Canada (B.R.d.C.) – sequence: 3 givenname: Tinh-Hai surname: Collet fullname: Collet, Tinh-Hai organization: Service of Endocrinology, Diabetes and Metabolism, University Hospital of Lausanne, Switzerland (T.-H.C.) – sequence: 4 givenname: Martin surname: Feller fullname: Feller, Martin organization: Department of General Internal Medicine, Inselspital, Bern University Hospital, (C.B., M.F., C.F., D.A., N.R.), Institute of Primary Health Care (BIHAM) (B.R.d.C., M.F., N.R.) – sequence: 5 givenname: Carmen surname: Floriani fullname: Floriani, Carmen organization: Department of General Internal Medicine, Inselspital, Bern University Hospital, (C.B., M.F., C.F., D.A., N.R.) – sequence: 6 givenname: Douglas C. surname: Bauer fullname: Bauer, Douglas C. organization: Departments of Medicine and Epidemiology and Biostatistics, University of California, San Francisco (D.C.B.) – sequence: 7 givenname: Anne R. surname: Cappola fullname: Cappola, Anne R. organization: University of Pennsylvania School of Medicine, Philadelphia (A.R.C.) – sequence: 8 givenname: Susan R. surname: Heckbert fullname: Heckbert, Susan R. organization: Department of Epidemiology, University of Washington, Seattle (S.R.H.) – sequence: 9 givenname: Graziano surname: Ceresini fullname: Ceresini, Graziano organization: Department of Clinical and Experimental Medicine, Geriatric Endocrine Unit, University Hospital of Parma, Italy (G.C.) – sequence: 10 givenname: Jacobijn surname: Gussekloo fullname: Gussekloo, Jacobijn organization: Department of Public Health and Primary Care, and Department of Gerontology and Geriatrics (J.G.) – sequence: 11 givenname: Wendy P.J. surname: den Elzen fullname: den Elzen, Wendy P.J. organization: Department of Clinical Chemistry and Laboratory Medicine (W.P.J.d.E.) – sequence: 12 givenname: Robin P. surname: Peeters fullname: Peeters, Robin P. organization: Leiden University Medical Center, The Netherlands; Departments of Internal Medicine and Epidemiology (R.P.P.) – sequence: 13 givenname: Robert surname: Luben fullname: Luben, Robert organization: Erasmus Medical Center, Rotterdam, The Netherlands; Department of Public Health and Primary Care, University of Cambridge, Addenbrooke’s Hospital, United Kingdom (R.L., K.-T.K.) – sequence: 14 givenname: Henry surname: Völzke fullname: Völzke, Henry organization: Institute for Community Medicine, Clinical-Epidemiological Research (H.V.) – sequence: 15 givenname: Marcus surname: Dörr fullname: Dörr, Marcus organization: Department of Internal Medicine (M.D.) – sequence: 16 givenname: John P. surname: Walsh fullname: Walsh, John P. organization: University Medicine Greifswald, Germany, and German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Germany; School of Medicine and Pharmacology, University of Western Australia, Crawley, Australia (J.P.W.);, Department of Endocrinology and Diabetes, Sir Charles Gairdner Hospital, Nedlands, Australia (J.P.W.) – sequence: 17 givenname: Alexandra surname: Bremner fullname: Bremner, Alexandra organization: School of Population Health, University of Western Australia, Crawley, Australia (A.B.) – sequence: 18 givenname: Massimo surname: Iacoviello fullname: Iacoviello, Massimo organization: Cardiology Unit, Department of Emergency and Organ Transplantation, University of Bari, Italy (M.I.) – sequence: 19 givenname: Peter surname: Macfarlane fullname: Macfarlane, Peter organization: Institute of Health and Wellbeing (P.M.) – sequence: 20 givenname: Jan surname: Heeringa fullname: Heeringa, Jan organization: Department of Epidemiology and Biostatistics (J.H.) – sequence: 21 givenname: David J. surname: Stott fullname: Stott, David J. organization: Institute of Cardiovascular and Medical Sciences, (D.J.S.) – sequence: 22 givenname: Rudi G. J. surname: Westendorp fullname: Westendorp, Rudi G. J. organization: University of Glasgow, United Kingdom; Department of Public Health and Center for Healthy Aging, University of Copenhagen, Denmark (R.G.J.W.) – sequence: 23 givenname: Kay-Tee surname: Khaw fullname: Khaw, Kay-Tee organization: Erasmus Medical Center, Rotterdam, The Netherlands; Department of Public Health and Primary Care, University of Cambridge, Addenbrooke’s Hospital, United Kingdom (R.L., K.-T.K.) – sequence: 24 givenname: Jared W. surname: Magnani fullname: Magnani, Jared W. organization: Heart and Vascular Institute, Department of Medicine, University of Pittsburgh, PA (J.W.M.) – sequence: 25 givenname: Drahomir surname: Aujesky fullname: Aujesky, Drahomir organization: Department of General Internal Medicine, Inselspital, Bern University Hospital, (C.B., M.F., C.F., D.A., N.R.) – sequence: 26 givenname: Nicolas surname: Rodondi fullname: Rodondi, Nicolas organization: Department of General Internal Medicine, Inselspital, Bern University Hospital, (C.B., M.F., C.F., D.A., N.R.), Institute of Primary Health Care (BIHAM) (B.R.d.C., M.F., N.R.) |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29061566$$D View this record in MEDLINE/PubMed |
BookMark | eNqNUU1vEzEUtFARTQt_AZkbh26xvf5YX0CriJBIUSuFVBwtx_E2hl072F6k_HvcpFSUEyfL783Me2_mApz54C0A7zC6xpjjD9PFanq3bNeL25t23paauEakEax-ASaYEVpRVsszMEEIyUrUhJyDi5S-ly-vBXsFzolEHDPOJ8Ctd4cY3BbORm-yCx5-c3nnPMw7C29CHHQPV9rf2yv4ddyY3nlnSml-2Id8Yro0XEHtt0fGyqUfMHSwzdEV2Mxtout7_SD8GrzsdJ_sm8f3EtzNPq-n82p5-2UxbZeVoY3MlWY1pg2TttvyhlssTNdhvNG0tBGhprYdpsh2mtfUCqYbwyQjWJJyuOSU15fg40l3P24GuzXW56h7tY9u0PGggnbqece7nboPvxQTiNGjwPtHgRh-jjZlNbhkbDnD2zAmhSVjxUiCRIG-_XvW05A__haAPAFMDClF2z1BMFIPWarnWZaaUKcsC_fTP1zj8tHKsrbr_0PhN0EsqJQ |
CitedBy_id | crossref_primary_10_3390_cells11244047 crossref_primary_10_1111_cen_14342 crossref_primary_10_1016_j_tcm_2019_02_011 crossref_primary_10_1007_s10354_020_00761_2 crossref_primary_10_3389_fendo_2021_795492 crossref_primary_10_1210_clinem_dgac523 crossref_primary_10_1016_j_xfre_2021_11_006 crossref_primary_10_1016_S2213_8587_21_00285_0 crossref_primary_10_3389_fendo_2022_1024476 crossref_primary_10_1210_clinem_dgab272 crossref_primary_10_1097_XCE_0000000000000299 crossref_primary_10_1136_bmjopen_2019_029716 crossref_primary_10_3390_biomedicines11051452 crossref_primary_10_1111_jce_14183 crossref_primary_10_1161_CIRCULATIONAHA_117_031283 crossref_primary_10_1016_j_pop_2024_04_001 crossref_primary_10_31829_2640_6284_CRGO_1_1__104 crossref_primary_10_1507_endocrj_EJ20_0239 crossref_primary_10_3390_nu16162613 crossref_primary_10_22141_2224_0586_17_4_2021_237735 crossref_primary_10_2478_enr_2021_0022 crossref_primary_10_1093_ejendo_lvae117 crossref_primary_10_1136_bmjopen_2021_055219 crossref_primary_10_1161_CIR_0000000000000950 crossref_primary_10_1210_clinem_dgaa730 crossref_primary_10_26453_otjhs_1462646 crossref_primary_10_3389_fcvm_2023_1036888 crossref_primary_10_1210_clinem_dgaa975 crossref_primary_10_1038_s41467_018_06356_1 crossref_primary_10_1161_CIR_0000000000001123 crossref_primary_10_1161_CIRCULATIONAHA_118_036859 crossref_primary_10_4103_jpbs_JPBS_746_20 crossref_primary_10_1016_j_jcte_2020_100219 crossref_primary_10_1016_j_acvd_2024_08_002 crossref_primary_10_1210_clinem_dgae777 crossref_primary_10_1016_j_eprac_2025_01_004 crossref_primary_10_1016_j_hrtlng_2020_08_023 crossref_primary_10_1093_labmed_lmab098 crossref_primary_10_1016_j_eprac_2022_05_008 crossref_primary_10_1080_13543784_2024_2388583 crossref_primary_10_1007_s11154_022_09713_0 crossref_primary_10_1016_j_cardfail_2024_11_010 crossref_primary_10_3389_fcvm_2024_1344515 crossref_primary_10_1089_ct_2024_36_396_398 crossref_primary_10_1186_s12902_024_01743_w crossref_primary_10_1016_j_xjon_2024_02_009 crossref_primary_10_1097_MD_0000000000035623 crossref_primary_10_1007_s00380_023_02341_x crossref_primary_10_1016_S2213_8587_23_00227_9 crossref_primary_10_1055_a_2240_8087 crossref_primary_10_1007_s12020_022_03223_4 crossref_primary_10_1016_j_ijrobp_2022_12_016 crossref_primary_10_1111_ijcp_14963 crossref_primary_10_1016_j_eprac_2024_03_391 crossref_primary_10_3389_fpsyt_2022_774251 crossref_primary_10_3389_fendo_2021_651534 crossref_primary_10_4103_jicc_jicc_42_21 crossref_primary_10_1093_milmed_usae324 crossref_primary_10_3390_biomedicines10112670 crossref_primary_10_1016_j_fmc_2021_04_008 crossref_primary_10_1016_j_heliyon_2023_e16435 crossref_primary_10_1016_j_coemr_2018_01_008 crossref_primary_10_3389_fphys_2018_01397 crossref_primary_10_1080_00325481_2024_2419358 crossref_primary_10_1016_j_recesp_2020_10_022 crossref_primary_10_1089_thy_2024_0131 crossref_primary_10_1161_CIR_0000000000000659 crossref_primary_10_1093_eurheartj_ehaa612 crossref_primary_10_5334_gh_871 crossref_primary_10_1210_clinem_dgaa239 crossref_primary_10_3389_fendo_2023_1087958 crossref_primary_10_1093_gerona_glaa123 crossref_primary_10_1210_clinem_dgae793 crossref_primary_10_1001_jama_2018_13770 crossref_primary_10_1210_clinem_dgab444 crossref_primary_10_25005_2074_0581_2024_26_4_608_618 crossref_primary_10_1210_clinem_dgac136 crossref_primary_10_1016_j_etap_2019_01_012 crossref_primary_10_3389_fendo_2022_987397 crossref_primary_10_1001_jamacardio_2018_4635 crossref_primary_10_1371_journal_pone_0298860 crossref_primary_10_1097_MED_0000000000000818 crossref_primary_10_1089_ct_2019_31_165_168 crossref_primary_10_1093_bjsopen_zrac079 crossref_primary_10_1007_s00399_024_01030_0 crossref_primary_10_1161_JAHA_119_015343 crossref_primary_10_1155_2018_3239197 crossref_primary_10_1089_thy_2018_0416 crossref_primary_10_1007_s11239_024_03025_7 crossref_primary_10_2174_1381612826666201118094747 crossref_primary_10_1210_clinem_dgae860 crossref_primary_10_1371_journal_pone_0196631 crossref_primary_10_1210_jc_2018_01604 crossref_primary_10_1159_000517092 crossref_primary_10_1016_j_ijscr_2023_108252 crossref_primary_10_3390_ijms21082844 crossref_primary_10_1038_s41598_024_64750_w crossref_primary_10_1002_clc_23117 crossref_primary_10_1210_clinem_dgad250 crossref_primary_10_1177_03000605231223040 crossref_primary_10_2147_TCRM_S433489 crossref_primary_10_1155_2021_6616681 crossref_primary_10_1038_s41598_021_98954_1 crossref_primary_10_1161_CIR_0000000000000757 crossref_primary_10_1161_CIR_0000000000001209 crossref_primary_10_1371_journal_pone_0296413 crossref_primary_10_1111_ene_16555 crossref_primary_10_2174_1573405619666221222105801 crossref_primary_10_4196_kjpp_2023_27_1_1 crossref_primary_10_3389_fendo_2022_920854 crossref_primary_10_3389_fendo_2019_00664 crossref_primary_10_3389_fendo_2022_1021326 crossref_primary_10_1161_CIR_0000000000001052 crossref_primary_10_1007_s40618_021_01590_9 crossref_primary_10_11106_ijt_2023_16_1_32 crossref_primary_10_1016_j_jss_2023_09_060 crossref_primary_10_1210_clinem_dgae610 crossref_primary_10_1210_jc_2018_00183 crossref_primary_10_1001_jamacardio_2018_4614 crossref_primary_10_1007_s12020_024_03838_9 crossref_primary_10_1371_journal_pone_0261160 crossref_primary_10_1016_j_bbagrm_2019_194435 crossref_primary_10_1038_s41467_024_44701_9 crossref_primary_10_1038_s41598_025_90491_5 crossref_primary_10_3390_jcm7100296 crossref_primary_10_1159_000499751 crossref_primary_10_1097_HJH_0000000000002655 crossref_primary_10_1371_journal_pone_0268070 crossref_primary_10_31829_2640_6284_crgo2018_1_1__104 crossref_primary_10_1007_s10654_020_00618_3 crossref_primary_10_1007_s40618_023_02159_4 crossref_primary_10_1161_JAHA_118_009158 crossref_primary_10_1210_clinem_dgae001 crossref_primary_10_1001_jama_2019_9052 crossref_primary_10_23736_S2724_6507_20_03176_4 crossref_primary_10_2147_DMSO_S436381 crossref_primary_10_1016_j_ahj_2020_09_016 crossref_primary_10_4081_jbr_2021_10067 crossref_primary_10_1016_j_hrthm_2024_05_021 crossref_primary_10_1055_a_1232_7292 crossref_primary_10_1007_s11739_022_03071_0 crossref_primary_10_1016_j_amjcard_2021_11_017 crossref_primary_10_18632_aging_204352 crossref_primary_10_1016_j_eprac_2020_10_018 crossref_primary_10_1053_j_jvca_2019_08_020 crossref_primary_10_1089_thy_2019_0535 crossref_primary_10_1007_s12020_019_01968_z crossref_primary_10_3389_fendo_2019_00889 crossref_primary_10_3389_fendo_2024_1418766 crossref_primary_10_1161_CIR_0000000000001303 crossref_primary_10_1161_CIRCULATIONAHA_116_022362 crossref_primary_10_3389_fendo_2021_758043 crossref_primary_10_1016_j_jccase_2024_06_009 crossref_primary_10_1093_eurheartj_ehae176 crossref_primary_10_1007_s12020_021_02851_6 crossref_primary_10_1016_j_clinbiochem_2018_05_003 crossref_primary_10_3389_fimmu_2019_02349 crossref_primary_10_5662_wjm_v12_i5_402 crossref_primary_10_3390_metabo13010022 crossref_primary_10_1016_j_eprac_2024_12_015 crossref_primary_10_1016_j_ijcard_2017_11_096 crossref_primary_10_1016_j_jbi_2020_103548 crossref_primary_10_1186_s12916_021_01921_w crossref_primary_10_36660_ijcs_20200113 |
Cites_doi | 10.1001/archinte.165.21.2460 10.1136/bmj.c221 10.1056/NEJM198201073060107 10.1161/CIRCULATIONAHA.112.096024 10.1111/jgs.12267 10.1136/bmj.e7895 10.1055/s-0035-1564131 10.1210/jc.2016-2255 10.1001/archinte.165.21.2467 10.1001/jama.295.9.1033 10.1210/jc.2012-4223 10.1136/bmj.i5130 10.1001/jama.2015.3656 10.1001/jama.291.2.228 10.1001/archinte.160.4.526 10.1016/S0002-9343(99)80348-9 10.1161/CIRCULATIONAHA.113.005119 10.1161/CIR.0000000000000041 10.1210/jc.2014-3586 10.1530/EJE-09-0566 10.1210/jcem.87.2.8182 10.1001/jama.2010.1361 10.1001/archinternmed.2009.138 10.1001/archinte.168.20.2219 10.1177/2047487314544045 10.1210/jcem.85.12.7085 10.1530/EJE-14-0898 10.1001/jama.292.21.2591 10.1172/JCI107014 10.1056/NEJM199207093270206 10.1016/j.ahj.2013.10.012 10.7326/0003-4819-137-11-200212030-00011 10.1001/archinte.167.9.928 10.1210/jc.2011-1978 10.7326/0003-4819-140-2-200401200-00015 10.1016/j.amjcard.2015.09.025 10.1210/jc.2015-2480 10.1136/bmj.323.7306.224 10.1056/NEJM199411103311901 10.1001/jamainternmed.2013.11312 10.1001/archinte.168.8.855 10.1016/S0735-1097(01)01731-4 10.2174/138161208786264142 10.1001/archinternmed.2012.402 10.1161/01.CIR.98.10.946 10.1161/CIRCULATIONAHA.115.020789 10.7326/0003-4819-148-11-200806030-00225 |
ContentType | Journal Article |
Copyright | 2017 American Heart Association, Inc. |
Copyright_xml | – notice: 2017 American Heart Association, Inc. |
CorporateAuthor | Thyroid Studies Collaboration |
CorporateAuthor_xml | – name: Thyroid Studies Collaboration |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1161/CIRCULATIONAHA.117.028753 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1524-4539 |
EndPage | 2116 |
ExternalDocumentID | PMC5705446 29061566 10_1161_CIRCULATIONAHA_117_028753 |
Genre | Meta-Analysis Systematic Review Journal Article |
GrantInformation_xml | – fundername: Medical Research Council grantid: G0401527 – fundername: NHLBI NIH HHS grantid: N01 HC085082 – fundername: NHLBI NIH HHS grantid: U01 HL080295 – fundername: Medical Research Council grantid: MR/N003284/1 – fundername: NHLBI NIH HHS grantid: N01 HC055222 – fundername: NIA NIH HHS grantid: N01 AG062103 – fundername: NIA NIH HHS grantid: U01 AG042143 – fundername: NHLBI NIH HHS grantid: R01 HL070848 – fundername: NINR NIH HHS grantid: R01 NR012459 – fundername: NIA NIH HHS grantid: R01 AG028050 |
GroupedDBID | --- .-D .3C .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO AAYXX ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACDOF ACEWG ACGFO ACGFS ACILI ACLDA ACOAL ACRKK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADCYY ADGGA ADHPY AE3 AE6 AEBDS AEETU AENEX AFBFQ AFCHL AFDTB AFEXH AFMBP AFNMH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC ASPBG AVWKF AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C45 CITATION CS3 DIK DIWNM DU5 E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 K-A K-F K8S KD2 KMI KQ8 L-C L7B N9A N~7 N~B O9- OAG OAH OBH OCB ODMTH OGEVE OHH OHYEH OK1 OL1 OLB OLG OLH OLU OLV OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ~H1 CGR CUY CVF ECM EIF NPM 7X8 ADKSD ADSXY 5PM |
ID | FETCH-LOGICAL-c489t-a5314859efd686e17cff11ba4c48024c3ef140efa634e75a8c595219215296463 |
ISSN | 0009-7322 1524-4539 |
IngestDate | Thu Aug 21 17:34:16 EDT 2025 Mon Sep 08 02:38:26 EDT 2025 Tue Jun 24 01:32:01 EDT 2025 Tue Jul 01 03:21:00 EDT 2025 Thu Apr 24 22:50:52 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 22 |
Keywords | thyroxine atrial fibrillation thyrotropin hypothyroidism |
Language | English |
License | 2017 American Heart Association, Inc. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c489t-a5314859efd686e17cff11ba4c48024c3ef140efa634e75a8c595219215296463 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.117.028753 |
PMID | 29061566 |
PQID | 1955063207 |
PQPubID | 23479 |
PageCount | 17 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5705446 proquest_miscellaneous_1955063207 pubmed_primary_29061566 crossref_primary_10_1161_CIRCULATIONAHA_117_028753 crossref_citationtrail_10_1161_CIRCULATIONAHA_117_028753 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-11-28 |
PublicationDateYYYYMMDD | 2017-11-28 |
PublicationDate_xml | – month: 11 year: 2017 text: 2017-11-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Circulation (New York, N.Y.) |
PublicationTitleAlternate | Circulation |
PublicationYear | 2017 |
References | e_1_3_4_3_2 e_1_3_4_9_2 e_1_3_4_7_2 e_1_3_4_40_2 e_1_3_4_5_2 e_1_3_4_23_2 e_1_3_4_44_2 e_1_3_4_21_2 e_1_3_4_42_2 e_1_3_4_27_2 e_1_3_4_48_2 e_1_3_4_25_2 e_1_3_4_46_2 e_1_3_4_29_2 e_1_3_4_30_2 e_1_3_4_11_2 e_1_3_4_34_2 e_1_3_4_32_2 e_1_3_4_15_2 e_1_3_4_38_2 e_1_3_4_13_2 e_1_3_4_36_2 e_1_3_4_19_2 e_1_3_4_17_2 e_1_3_4_2_2 e_1_3_4_8_2 e_1_3_4_41_2 e_1_3_4_6_2 e_1_3_4_4_2 e_1_3_4_22_2 e_1_3_4_45_2 e_1_3_4_20_2 e_1_3_4_43_2 e_1_3_4_26_2 e_1_3_4_49_2 e_1_3_4_24_2 e_1_3_4_47_2 e_1_3_4_28_2 e_1_3_4_50_2 e_1_3_4_12_2 e_1_3_4_33_2 e_1_3_4_10_2 e_1_3_4_31_2 e_1_3_4_16_2 e_1_3_4_37_2 e_1_3_4_14_2 e_1_3_4_35_2 e_1_3_4_18_2 e_1_3_4_39_2 29180492 - Circulation. 2017 Nov 28;136(22):2117-2118. doi: 10.1161/CIRCULATIONAHA.117.031283. |
References_xml | – ident: e_1_3_4_26_2 doi: 10.1001/archinte.165.21.2460 – ident: e_1_3_4_19_2 doi: 10.1136/bmj.c221 – ident: e_1_3_4_48_2 doi: 10.1056/NEJM198201073060107 – ident: e_1_3_4_22_2 doi: 10.1161/CIRCULATIONAHA.112.096024 – ident: e_1_3_4_31_2 doi: 10.1111/jgs.12267 – ident: e_1_3_4_12_2 doi: 10.1136/bmj.e7895 – ident: e_1_3_4_49_2 doi: 10.1055/s-0035-1564131 – ident: e_1_3_4_23_2 doi: 10.1210/jc.2016-2255 – ident: e_1_3_4_34_2 doi: 10.1001/archinte.165.21.2467 – ident: e_1_3_4_14_2 doi: 10.1001/jama.295.9.1033 – ident: e_1_3_4_41_2 – ident: e_1_3_4_50_2 doi: 10.1210/jc.2012-4223 – ident: e_1_3_4_39_2 doi: 10.1136/bmj.i5130 – ident: e_1_3_4_21_2 doi: 10.1001/jama.2015.3656 – ident: e_1_3_4_35_2 doi: 10.1001/jama.291.2.228 – ident: e_1_3_4_7_2 doi: 10.1001/archinte.160.4.526 – ident: e_1_3_4_4_2 doi: 10.1016/S0002-9343(99)80348-9 – ident: e_1_3_4_2_2 doi: 10.1161/CIRCULATIONAHA.113.005119 – ident: e_1_3_4_6_2 doi: 10.1161/CIR.0000000000000041 – ident: e_1_3_4_15_2 doi: 10.1210/jc.2014-3586 – ident: e_1_3_4_30_2 doi: 10.1530/EJE-09-0566 – ident: e_1_3_4_8_2 doi: 10.1210/jcem.87.2.8182 – ident: e_1_3_4_11_2 doi: 10.1001/jama.2010.1361 – ident: e_1_3_4_27_2 doi: 10.1001/archinternmed.2009.138 – ident: e_1_3_4_17_2 doi: 10.1001/archinte.168.20.2219 – ident: e_1_3_4_33_2 doi: 10.1177/2047487314544045 – ident: e_1_3_4_45_2 doi: 10.1210/jcem.85.12.7085 – ident: e_1_3_4_40_2 doi: 10.1530/EJE-14-0898 – ident: e_1_3_4_29_2 doi: 10.1001/jama.292.21.2591 – ident: e_1_3_4_47_2 doi: 10.1172/JCI107014 – ident: e_1_3_4_5_2 doi: 10.1056/NEJM199207093270206 – ident: e_1_3_4_13_2 doi: 10.1016/j.ahj.2013.10.012 – ident: e_1_3_4_43_2 doi: 10.7326/0003-4819-137-11-200212030-00011 – ident: e_1_3_4_18_2 doi: 10.1001/archinte.167.9.928 – ident: e_1_3_4_32_2 doi: 10.1210/jc.2011-1978 – ident: e_1_3_4_36_2 doi: 10.7326/0003-4819-140-2-200401200-00015 – ident: e_1_3_4_46_2 doi: 10.1016/j.amjcard.2015.09.025 – ident: e_1_3_4_25_2 doi: 10.1210/jc.2015-2480 – ident: e_1_3_4_20_2 doi: 10.1136/bmj.323.7306.224 – ident: e_1_3_4_10_2 doi: 10.1056/NEJM199411103311901 – ident: e_1_3_4_42_2 doi: 10.1001/jamainternmed.2013.11312 – ident: e_1_3_4_38_2 doi: 10.1001/archinte.168.8.855 – ident: e_1_3_4_44_2 doi: 10.1016/S0735-1097(01)01731-4 – ident: e_1_3_4_28_2 doi: 10.2174/138161208786264142 – ident: e_1_3_4_9_2 doi: 10.1001/archinternmed.2012.402 – ident: e_1_3_4_24_2 – ident: e_1_3_4_3_2 doi: 10.1161/01.CIR.98.10.946 – ident: e_1_3_4_16_2 doi: 10.1161/CIRCULATIONAHA.115.020789 – ident: e_1_3_4_37_2 doi: 10.7326/0003-4819-148-11-200806030-00225 – reference: 29180492 - Circulation. 2017 Nov 28;136(22):2117-2118. doi: 10.1161/CIRCULATIONAHA.117.031283. |
SSID | ssj0006375 |
Score | 2.6273336 |
SecondaryResourceType | review_article |
Snippet | Atrial fibrillation (AF) is a highly prevalent disorder leading to heart failure, stroke, and death. Enhanced understanding of modifiable risk factors may... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 2100 |
SubjectTerms | Adult Aged Aged, 80 and over Asymptomatic Diseases Atrial Fibrillation - diagnosis Atrial Fibrillation - epidemiology Biomarkers - blood Chi-Square Distribution Female Humans Hypothyroidism - blood Hypothyroidism - diagnosis Hypothyroidism - epidemiology Hypothyroidism - physiopathology Incidence Male Middle Aged Predictive Value of Tests Prognosis Proportional Hazards Models Risk Assessment Risk Factors Thyroid Function Tests Thyroid Gland - metabolism Thyroid Gland - physiopathology Thyrotropin - blood Thyroxine - blood Time Factors Young Adult |
Title | Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29061566 https://www.proquest.com/docview/1955063207 https://pubmed.ncbi.nlm.nih.gov/PMC5705446 |
Volume | 136 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj5swELbSrbTqpWp3-0hf8kpVL1lSIMaGYxo1Squ2h2ij5oYMmA1SFlYpOaS_sT-qM9gQ2Kbqdi8oAmw5zMc88Mw3hLx1RRKIxONW4tqxxfhIWIHvQtQa-GkqnQQp6DDb4hufLdjnpbfs9X61spa2ZTSMfx6sK7mLVOEcyBWrZP9Dss2kcAJ-g3zhCBKG4y1lvNsUWTKYgnGq5Pg9K1d14iI6o-vBHIsHdPpN1FRBznbXKCAci4kXJoETR81NpvlYd_OYYkHAer2XXs1pkG1i0_frUDuf1ueFD3J7dQlLN3U1msugtZefSFBJxoVFFoRiMB82-yL4UaPUiMpX1kxme8e1rmDUNAjtbxdgDx2nrgWv9XFgiZGuTB4qo4JdZjFPUxw1OlqzpBgwmvtrlWvbLfMNAS0_bBo4mobJp_lk8UUTDc_GuGU9BA9LaMLiLh33DTPZJC9WYRN3wu5UyJoe6qnukfuuAE8OS8-X-4QjeA-8uq8f_udjcmbW9f6vq-p6S3-EQDczeVuu0cUj8tDENHSsAfqY9FR-Qk7HuSyLqx19R6ss42r75oQcfzXJHKckM_ClNXyphi8FIFINX1rB95y2wEu74D2nAN1qBEKXFinV0KVt6D4hi-nHi8nMMp0_rJj5QWlJsAzM9wKVJtznyhFxmjpOJBlcBqcyHqnUYbZKJR8xJTzpx14AfmiATZoDDhrnKTnKi1w9J9SHpx6BKfVtiJzjKJFI-JcIAXM4wlaqT_z6CYexocXH7izr8J9y7hO3GXqtuWFuM-isFmMImhy352Suiu2P0Ak8D0Di2qJPnmmxNtNiUwb80tInoiPw5gZkie9eybNVxRbvCYjKGH9xl8W-JA_2r-0rclRutuo1OOFl9KbC9m8ABdU1 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Thyroid+Function+Within+the+Normal+Range%2C+Subclinical+Hypothyroidism%2C+and+the+Risk+of+Atrial+Fibrillation&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Baumgartner%2C+Christine&rft.au=da+Costa%2C+Bruno+R.&rft.au=Collet%2C+Tinh-Hai&rft.au=Feller%2C+Martin&rft.date=2017-11-28&rft.issn=0009-7322&rft.eissn=1524-4539&rft.volume=136&rft.issue=22&rft.spage=2100&rft.epage=2116&rft_id=info:doi/10.1161%2FCIRCULATIONAHA.117.028753&rft.externalDBID=n%2Fa&rft.externalDocID=10_1161_CIRCULATIONAHA_117_028753 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon |